行情

ISEE

ISEE

IVERIC bio Inc
NASDAQ

实时行情|Nasdaq Last Sale

6.78
+0.09
+1.35%
盘后: 6.78 0 0.00% 16:45 01/17 EST
开盘
6.67
昨收
6.69
最高
6.92
最低
6.62
成交量
55.70万
成交额
--
52周最高
8.97
52周最低
0.9059
市值
3.25亿
市盈率(TTM)
4.191
分时
5日
1月
3月
1年
5年

分析师评级

1位分析师的综合评级

强力推荐

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

ISEE 新闻

  • 沪指震荡上扬 中国央行4天投放1.1万亿
  • 新浪财经.33分钟前
  • 英媒刊文:生产率下滑正困扰新兴经济体
  • 参考消息.4小时前
  • 戈恩为何决定逃亡?日媒揭秘:或因听闻审理将延期
  • 中国新闻网.4小时前
  • 日媒:戈恩从日本逃往黎巴嫩或因听闻审理将延期
  • 新京报网.4小时前

更多

所属板块

生物技术和医学研究
-0.16%
制药与医学研究
+0.06%

热门股票

名称
价格
涨跌幅

ISEE 简况

IVERIC bio, Inc., formerly Ophthotech Corporation, is a biopharmaceutical company. The Company is focused on the discovering and developing of novel gene therapy solutions to treat orphan inherited retinal diseases, with a focus on diseases of the back of the eye. Its primary focus is developing therapeutics for age-related macular degeneration (AMD), which is a disorder of the central portion of the retina, known as the macula, that may result in blindness. The Company’s BEST1 gene encodes a multifunctional protein known as bestrophin1, that regulates ion transport and intracellular calcium signaling in retina cells and helps maintain homeostasis in the sub retinal space between photoreceptors and the retinal pigment epithelial (RPE) cells. Its IC-200 is a mutation independent gene therapy, delivered by an AAV2 vector.
展开

Webull提供IVERIC bio Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。